Generating a taxonomy for genetic conditions relevant to reproductive planning
- PMID: 26889673
- PMCID: PMC4860293
- DOI: 10.1002/ajmg.a.37513
Generating a taxonomy for genetic conditions relevant to reproductive planning
Abstract
As genome or exome sequencing (hereafter genome-scale sequencing) becomes more integrated into standard care, carrier testing is an important possible application. Carrier testing using genome-scale sequencing can identify a large number of conditions, but choosing which conditions/genes to evaluate as well as which results to disclose can be complicated. Carrier testing generally occurs in the context of reproductive decision-making and involves patient values in a way that other types of genetic testing may not. The Kaiser Permanente Clinical Sequencing Exploratory Research program is conducting a randomized clinical trial of preconception carrier testing that allows participants to select their preferences for results from among broad descriptive categories rather than selecting individual conditions. This paper describes (1) the criteria developed by the research team, the return of results committee (RORC), and stakeholders for defining the categories; (2) the process of refining the categories based on input from patient focus groups and validation through a patient survey; and (3) how the RORC then assigned specific gene-condition pairs to taxonomy categories being piloted in the trial. The development of four categories (serious, moderate/mild, unpredictable, late onset) for sharing results allows patients to select results based on their values without separately deciding their interest in knowing their carrier status for hundreds of conditions. A fifth category, lifespan limiting, was always shared. The lessons learned may be applicable in other results disclosure situations, such as incidental findings.
Keywords: carrier testing; genome sequencing; return of results.
© 2016 Wiley Periodicals, Inc.
Conflict of interest statement
None of the authors have conflicts of interest to declare.
Figures
References
-
- ACOG Committee Opinion No. 442: Preconception and prenatal carrier screening for genetic diseases in individuals of Eastern European Jewish descent. Obstetrics and gynecology. 2009;114(4):950–953. - PubMed
-
- ACOG Committee Opinion No. 486: Update on carrier screening for cystic fibrosis. Obstetrics and gynecology. 2011;117(4):1028–1031. - PubMed
-
- Boardman FK. The expressivist objection to prenatal testing: the experiences of families living with genetic disease. Social science & medicine (1982) 2014;107:18–25. - PubMed
-
- de Jong A, Dondorp WJ, Frints SG, de Die-Smulders CE, de Wert GM. Advances in prenatal screening: the ethical dimension. Nature reviews Genetics. 2011;12(9):657–663. - PubMed
-
- Elias S, Annas GJ. Generic consent for genetic screening. The New England journal of medicine. 1994;330(22):1611–1613. - PubMed
Publication types
MeSH terms
Grants and funding
- U01 HG006375/HG/NHGRI NIH HHS/United States
- U01HG006375/HG/NHGRI NIH HHS/United States
- U01 HG008657/HG/NHGRI NIH HHS/United States
- K01 HG008180/HG/NHGRI NIH HHS/United States
- U01 HG006507/HG/NHGRI NIH HHS/United States
- U01HG007307/HG/NHGRI NIH HHS/United States
- U01HG006507/HG/NHGRI NIH HHS/United States
- K01HG008180/HG/NHGRI NIH HHS/United States
- UM1 HG007292/HG/NHGRI NIH HHS/United States
- UM1HG007292/HG/NHGRI NIH HHS/United States
- U01 HG007307/HG/NHGRI NIH HHS/United States
- U01 HG006487/HG/NHGRI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials